Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
暂无分享,去创建一个
William L. Smith | B. Lucchesi | R. Trievel | Ryan A Frieler | G. Rimon | Chong Yuan | Raymond C. Trievel | Ryan A. Frieler | C. Yuan | Gilad Rimon | Ranjinder S. Sidhu | D. Adam Lauver | Jullia Y. Lee | Narayan P. Sharma | Benedict R. Lucchesi | R. S. Sidhu | D. Lauver | W. Smith
[1] C. Serhan,et al. Divergent cyclooxygenase responses to fatty acid structure and peroxide level in fish and mammalian prostaglandin H synthases , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] William L. Smith,et al. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. , 2008, Trends in biochemical sciences.
[3] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[4] Lawrence J Marnett,et al. Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. , 2003, Chemical reviews.
[5] M. Rosenstock,et al. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity. , 1999, Biochimica et biophysica acta.
[6] W. Lands,et al. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. , 1985, The Journal of biological chemistry.
[7] M. Rosenstock,et al. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs. , 2001, European journal of pharmacology.
[8] G. Rimon,et al. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1. , 2002, European journal of pharmacology.
[9] S. Waldman,et al. A New Cyclooxygenase‐2 Inhibitor, Rofecoxib (VIOXX®), Did Not Alter the Antiplatelet Effects of Low‐Dose Aspirin in Healthy Volunteers , 2000, Journal of clinical pharmacology.
[10] B. Wingerd,et al. Partnering between monomers of cyclooxygenase-2 homodimers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Malkowski,et al. The productive conformation of arachidonic acid bound to prostaglandin synthase. , 2000, Science.
[12] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[13] R. Copeland,et al. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Chow,et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.
[15] F. Gengo,et al. Prevalence of Platelet Nonresponsiveness to Aspirin in Patients Treated for Secondary Stroke Prophylaxis and in Patients With Recurrent Ischemic Events , 2008, Journal of clinical pharmacology.
[16] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[17] M. Percival,et al. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] Kwang-Hyeon Liu,et al. Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers. , 2008, Biomedical chromatography : BMC.
[19] Lawrence J. Marnett,et al. Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-α-Substituted Indomethacin Ethanolamides* , 2007, Journal of Biological Chemistry.
[20] L. Crofford,et al. Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries , 2001, Circulation.
[21] L. Marnett,et al. Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid† , 2009, Biochemistry.
[22] R. Kurumbail,et al. A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. , 2001, The Biochemical journal.
[23] Garret A FitzGerald,et al. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.
[24] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[25] Celecoxib Does Not Affect the Antiplatelet Activity of Aspirin in Healthy Volunteers , 2002, Journal of clinical pharmacology.
[26] W. A. van der Donk,et al. The cyclooxygenase reaction mechanism. , 2002, Biochemistry.
[27] M. L. Jones,et al. PDBsum: a Web-based database of summaries and analyses of all PDB structures. , 1997, Trends in biochemical sciences.
[28] O. Boutaud,et al. Acetylation of prostaglandin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase. , 2008, Biochemical pharmacology.
[29] J. Lötsch,et al. The cyclooxygenase 2 genetic variant −765G>C does not modulate the effects of celecoxib on prostaglandin E2 production , 2006, Clinical pharmacology and therapeutics.
[30] Jack Snoeyink,et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007, Nucleic Acids Res..
[31] P. Gladding,et al. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. , 2008, The American journal of cardiology.
[32] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[33] Randy J Read,et al. Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .
[34] L. Marnett,et al. Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids* , 2008, Journal of Biological Chemistry.
[35] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1997, Nature.
[36] Jaime Prilusky,et al. Automated analysis of interatomic contacts in proteins , 1999, Bioinform..
[37] William L. Smith,et al. Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers* , 2009, Journal of Biological Chemistry.
[38] R. Garavito,et al. Crystal Structure of Arachidonic Acid Bound to a Mutant of Prostaglandin Endoperoxide H Synthase-1 That Forms Predominantly 11-Hydroperoxyeicosatetraenoic Acid* , 2004, Journal of Biological Chemistry.
[39] A. Mulichak,et al. The Role of Arginine 120 of Human Prostaglandin Endoperoxide H Synthase-2 in the Interaction with Fatty Acid Substrates and Inhibitors* , 1999, The Journal of Biological Chemistry.
[40] Claus Schneider,et al. Control of oxygenation in lipoxygenase and cyclooxygenase catalysis. , 2007, Chemistry & biology.
[41] J. Eikelboom,et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. , 2002, The New England journal of medicine.
[42] William L. Smith,et al. Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products*♦ , 2007, Journal of Biological Chemistry.
[43] D. Dewitt,et al. Cox-2-selective inhibitors: the new super aspirins. , 1999, Molecular pharmacology.
[44] Z. Halıcı,et al. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. , 2008, Current medicinal chemistry.
[45] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[46] D. Breuer,et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. , 1994, The Journal of pharmacology and experimental therapeutics.
[47] Randy J Read,et al. Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .